NO981222D0 - Ny kombinasjon av en <beta>-reseptorblokker og et opioid - Google Patents

Ny kombinasjon av en <beta>-reseptorblokker og et opioid

Info

Publication number
NO981222D0
NO981222D0 NO981222A NO981222A NO981222D0 NO 981222 D0 NO981222 D0 NO 981222D0 NO 981222 A NO981222 A NO 981222A NO 981222 A NO981222 A NO 981222A NO 981222 D0 NO981222 D0 NO 981222D0
Authority
NO
Norway
Prior art keywords
pct
opioid
beta
receptor blocker
pharmaceutically acceptable
Prior art date
Application number
NO981222A
Other languages
English (en)
Other versions
NO981222L (no
NO318387B1 (no
Inventor
Arne Eek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO981222L publication Critical patent/NO981222L/no
Publication of NO981222D0 publication Critical patent/NO981222D0/no
Publication of NO318387B1 publication Critical patent/NO318387B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medicines Containing Plant Substances (AREA)
NO19981222A 1995-10-06 1998-03-18 Anvendelse av en kombinasjon av en beta-reseptorblokker og et opioid ved behandling av smerte. NO318387B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9503476A SE9503476D0 (sv) 1995-10-06 1995-10-06 New combination
PCT/SE1996/001248 WO1997012634A1 (en) 1995-10-06 1996-10-03 A NOVEL COMBINATION OF A β-RECEPTOR BLOCKER AND AN OPIOID

Publications (3)

Publication Number Publication Date
NO981222L NO981222L (no) 1998-03-18
NO981222D0 true NO981222D0 (no) 1998-03-18
NO318387B1 NO318387B1 (no) 2005-03-14

Family

ID=20399727

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981222A NO318387B1 (no) 1995-10-06 1998-03-18 Anvendelse av en kombinasjon av en beta-reseptorblokker og et opioid ved behandling av smerte.

Country Status (14)

Country Link
US (1) US5908847A (no)
EP (1) EP0862462B1 (no)
JP (1) JP4135977B2 (no)
AT (1) ATE259657T1 (no)
AU (1) AU706794B2 (no)
CA (1) CA2233677C (no)
DE (1) DE69631597T2 (no)
DK (1) DK0862462T3 (no)
ES (1) ES2214548T3 (no)
NO (1) NO318387B1 (no)
NZ (1) NZ319746A (no)
PT (1) PT862462E (no)
SE (1) SE9503476D0 (no)
WO (1) WO1997012634A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100306707B1 (ko) * 1998-09-07 2003-01-24 한국전기통신공사 교차이득변조형반도체광파장변환기
US7041365B2 (en) * 2003-05-12 2006-05-09 3M Innovative Properties Company Static dissipative optical construction
JP2013523764A (ja) * 2010-03-30 2013-06-17 アルジーノミクス インコーポレイテッド 体性感覚障害治療用の組成物と方法
US8716350B2 (en) 2010-03-30 2014-05-06 Algynomics Inc. Compositions and methods for the treatment of somatosensory disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities

Also Published As

Publication number Publication date
AU706794B2 (en) 1999-06-24
NO981222L (no) 1998-03-18
AU7233596A (en) 1997-04-28
WO1997012634A1 (en) 1997-04-10
EP0862462A1 (en) 1998-09-09
DE69631597T2 (de) 2004-12-16
US5908847A (en) 1999-06-01
NO318387B1 (no) 2005-03-14
DK0862462T3 (da) 2004-05-10
SE9503476D0 (sv) 1995-10-06
CA2233677C (en) 2006-08-29
ES2214548T3 (es) 2004-09-16
NZ319746A (en) 1999-11-29
JP4135977B2 (ja) 2008-08-20
CA2233677A1 (en) 1997-04-10
DE69631597D1 (de) 2004-03-25
JPH11513386A (ja) 1999-11-16
EP0862462B1 (en) 2004-02-18
ATE259657T1 (de) 2004-03-15
PT862462E (pt) 2004-06-30

Similar Documents

Publication Publication Date Title
DK0744944T3 (da) Transdermale terapeutiske systemer indeholdende kønssterioder
HU9203779D0 (en) (+)-alpha-(2,3-dimethoxi-phenyl)-1-[2-(4-fluoric-phenyl)-ethyl]-4-piperidine-methanole
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
DE69805973T2 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
EP1244446A4 (en) Thrombopoietin mimetics
DE69711078T2 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
NO981222D0 (no) Ny kombinasjon av en &lt;beta&gt;-reseptorblokker og et opioid
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
DK0840607T3 (da) Ny medicinsk anvendelse
DE69427116T2 (de) Verwendung von 4&#39;-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
GB9802542D0 (en) New use
AU4944899A (en) New pharmaceutically active compounds
HK1046847A1 (en) Pharmaceutical combination with analgesic action containing paracetamol and buspirone.
BG105289A (en) The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2- (4-fluorophenyl)ethyl]-4-pip eridinemethanol for the treatment of sleep disorders
MX9701526A (es) Terapia combinada para tratar la osteoporosis.
MX9701529A (es) Uso de (e)-1-[4&#39;-(2-alquilaminoetoxi)fenil]-1-(3&#39;-hidroxifenil)-2-f enilbut-1-enos para inhibir trastornos patologicos.
MX9701528A (es) Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.
MX9701532A (es) Procedimiento para aumentar los niveles de testosterona.
BG100479U (en) Medicament for the local treatment of otitis

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees